ZLAB vs XENE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 19, 2026

ZLAB

33.0
AI Score
VS
XENE Wins

XENE

56.5
AI Score

Investment Advisor Scores

ZLAB

33score
Recommendation
SELL

XENE

57score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ZLAB XENE Winner
Revenue 205.92M 264,000 ZLAB
Net Income -101.84M -22.64M XENE
Net Margin -49.5% -8575.4% ZLAB
Operating Income -145.87M -24.52M XENE
ROE -16.8% -52.3% ZLAB
ROA -9.5% -48.8% ZLAB
Total Assets 1.07B 46.36M ZLAB
Cash 607.52M 14.69M ZLAB
Free Cash Flow -77.82M -22.14M XENE

Relative Price Performance (Last 90 Days)

ZLAB 1M: +32.2% · 3M: +36.2% XENE 1M: -7.1% · 3M: +12.3%

Current Technical Phase

ZLAB

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (9.0% over 20 days), RSI 71

RSI (14): 71.5 · Price: $26.01

XENE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.3 · Price: $60.77

Fundamentals Snapshot

Metric ZLAB XENE
Market Cap
Forward P/E -12.6 -12.3
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% -1.0%
Gross Margin 0.0%
Operating Margin -0.7% 0.0%
EPS -1.78 -4.64
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, XENE is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.